Fulcrum Therapeutics to Participate in Upcoming December Conferences
Fulcrum Therapeutics (Nasdaq: FULC), a clinical-stage biopharmaceutical company developing small molecules for rare genetic diseases, has announced its participation in three major healthcare conferences this December. The company will present at the Piper Sandler 36th Annual Healthcare Conference on December 3 with a fireside chat at 12:00 pm ET in New York, the Citi 2024 Global Healthcare Conference on December 4 in Miami, and the Evercore ISI 7th Annual HealthCONx Conference on December 5 in Miami. The Piper Sandler fireside chat webcast will be available on Fulcrum's website for at least 30 days after the presentation.
Fulcrum Therapeutics (Nasdaq: FULC), un'azienda biofarmaceutica in fase clinica che sviluppa piccole molecole per malattie genetiche rare, ha annunciato la sua partecipazione a tre importanti conferenze sanitarie questo dicembre. L'azienda presenterà al Piper Sandler 36th Annual Healthcare Conference il 3 dicembre con una chiacchierata informale alle 12:00 ET a New York, al Citi 2024 Global Healthcare Conference il 4 dicembre a Miami, e al Evercore ISI 7th Annual HealthCONx Conference il 5 dicembre a Miami. La trasmissione in web del fireside chat di Piper Sandler sarà disponibile sul sito web di Fulcrum per almeno 30 giorni dopo la presentazione.
Fulcrum Therapeutics (Nasdaq: FULC), una compañía biofarmacéutica en etapa clínica que desarrolla moléculas pequeñas para enfermedades genéticas raras, ha anunciado su participación en tres importantes conferencias de salud este diciembre. La compañía presentará en el Piper Sandler 36th Annual Healthcare Conference el 3 de diciembre con una charla informal a las 12:00 pm ET en Nueva York, en el Citi 2024 Global Healthcare Conference el 4 de diciembre en Miami, y en el Evercore ISI 7th Annual HealthCONx Conference el 5 de diciembre en Miami. La transmisión web de la charla de Piper Sandler estará disponible en el sitio web de Fulcrum por al menos 30 días después de la presentación.
Fulcrum Therapeutics (Nasdaq: FULC)는 희귀 유전 질환을 위한 소분자 개발을 전문으로 하는 임상 단계의 생명공학 회사로, 이번 12월에 세 가지 주요 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사는 12월 3일 뉴욕에서 Piper Sandler 제36회 연례 헬스케어 컨퍼런스에서 오후 12:00 ET에 파이어사이드 채팅을 진행하고, 12월 4일 마이애미에서 Citi 2024 글로벌 헬스케어 컨퍼런스에 참석하며, 12월 5일 마이애미에서 Evercore ISI 제7회 HealthCONx 컨퍼런스에도 참석할 예정입니다. Piper Sandler의 파이어사이드 채팅 웹캐스트는 발표 후 최소 30일 동안 Fulcrum의 웹사이트에서 시청 가능합니다.
Fulcrum Therapeutics (Nasdaq: FULC), une société bio-pharmaceutique en phase clinique développant de petites molécules pour des maladies génétiques rares, a annoncé sa participation à trois grandes conférences sur la santé en décembre. L'entreprise présentera lors de la Piper Sandler 36th Annual Healthcare Conference le 3 décembre avec une discussion informelle à 12h00 ET à New York, à la Citi 2024 Global Healthcare Conference le 4 décembre à Miami, et à la Evercore ISI 7th Annual HealthCONx Conference le 5 décembre à Miami. Le webinaire du Fireside Chat de Piper Sandler sera disponible sur le site de Fulcrum pendant au moins 30 jours après la présentation.
Fulcrum Therapeutics (Nasdaq: FULC), ein biopharmazeutisches Unternehmen in der klinischen Phase, das kleine Moleküle für seltene genetische Erkrankungen entwickelt, hat seine Teilnahme an drei wichtigen Gesundheitskonferenzen im Dezember bekannt gegeben. Das Unternehmen wird am 3. Dezember um 12:00 Uhr ET in New York beim Piper Sandler 36th Annual Healthcare Conference mit einem Fireside Chat präsentieren, am 4. Dezember beim Citi 2024 Global Healthcare Conference in Miami und am 5. Dezember beim Evercore ISI 7th Annual HealthCONx Conference in Miami. Der Webcast des Fireside Chats von Piper Sandler wird nach der Präsentation mindestens 30 Tage lang auf der Website von Fulcrum verfügbar sein.
- None.
- None.
CAMBRIDGE, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will participate in the following conferences:
- Piper Sandler 36th Annual Healthcare Conference
December 3, 2024
Fireside Chat at 12:00 pm ET, Participation link: HERE
New York, New York
- Citi 2024 Global Healthcare Conference
December 4, 2024
Miami, Florida
- Evercore ISI 7th Annual HealthCONx Conference
December 5, 2024
Miami, Florida
The webcast of the Piper Sandler fireside chat will be accessible by visiting the "Events and Presentations" section of Fulcrum Therapeutics’ website at https://ir.fulcrumtx.com/events-and-presentations. A replay of the webcasts will be available on Fulcrum Therapeutics’ website for at least 30 days following the presentations.
About Fulcrum Therapeutics
Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases in areas of high unmet medical need. Fulcrum’s lead program in clinical development is pociredir, a small molecule designed to increase expression of fetal hemoglobin and in development for the treatment of sickle cell disease (SCD). Fulcrum uses proprietary technology to identify drug targets that can modulate gene expression to treat the known root cause of gene mis-expression. For more information, visit www.fulcrumtx.com and follow us on Twitter/X (@FulcrumTx) and LinkedIn.
Contact:
Chris Calabrese
LifeSci Advisors, LLC
ccalabrese@lifesciadvisors.com
917-680-5608
FAQ
What healthcare conferences is Fulcrum Therapeutics (FULC) attending in December 2024?
When is Fulcrum Therapeutics' (FULC) fireside chat at the Piper Sandler conference?
Where can I watch Fulcrum Therapeutics' (FULC) Piper Sandler presentation?
